Leading Japanese pharmaceutical company praises Copenhagen’s approach to business
All locations can offer something great, however Copenhagen has a more entrepreneurial approach to doing business and there are more incubators.
Placing a Nordic headquarter in Copenhagen comes with numerous strategic benefits. For example, Daiichi Sankyo will reside at Copenhagen Bio Science Park, COBIS, which is located in central Copenhagen among neighbours such as Copenhagen University Hospital, Faculty of Health Sciences and the Faculty of Pharmaceutical Sciences from Copenhagen University.
Direct connection to the heart of research and treatment
Innovation is vital in everything we do, from pursuing new medicines and new methods of drug discovery and delivery, to achieving excellence throughout our organisation by continuously examining new ideas. This is why we have decided to established our new affiliate at COBIS. It connect us directly with the heart of research and treatment.
We are already very engaged in a couple of projects and plan to be an active participant in the ecosystem around the Medicon Valley region, where we are especially impressed by the high level of R&D and clinical research within oncology.
Why establish your nordic base in Denmark?
1. We are consistently ranked as one of the easiest places to do business, while also being among the least corrupt countries in the world.
2. Our efficient public sector as well as the unique collaboration opportunities between public and private partners sets us apart as an attractive investment destination.
3. We have a strong, innovative and productive healthcare industry, covering pharmaceuticals, biotechnology, medical technology and eHealth.
4. Danes are motivated, well-educated and efficient – a highly attractive asset for foreign companies operating in Denmark.